Li Xiaojian, Huang Xiangyan, Wu Wen, Guo Xingying
School of Medical Laboratory, Weifang Medical University, Weifang, Shandong 261053, China.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2021 May 10;38(5):496-498. doi: 10.3760/cma.j.cn511374-20200804-00581.
To delineate the serological and molecular profiles of a patient with A(w)37B subtype.
The ABO bloodtypes of the proband, his wife and daughter were determined with a standard serological method. Their ABO genotypes were determined by sequence-specific primer polymerase chain reaction (PCR-SSP). All exons of the ABO gene were directly sequenced. Exons 6 and 7 of the ABO gene were further analyzed by cloning and sequencing.
The red blood cells of the proband showed a weak B phenotype. His serum sample contained weak reactive anti-A antibody, which was defined as A(w)B blood group based on the serological characteristics. The A and B alleles were detected by blood group genotyping. Gene cloning and sequencing have identified a characteristic c.940A>G variant (ABOAW.37) in exon 7 of the ABO gene, which resulted in substitution of Lysine by Glutamate at position 314. The proband's daughter has inherited the ABOAW.37 allele.
The c.940A>G variant in exon 7 of the ABO gene probably underlay the decreased activity of GTA transferase and resulted in the Aw37 phenotype.
描绘一名A(w)37B亚型患者的血清学和分子特征。
采用标准血清学方法测定先证者、其妻子和女儿的ABO血型。通过序列特异性引物聚合酶链反应(PCR-SSP)确定他们的ABO基因型。对ABO基因的所有外显子进行直接测序。通过克隆和测序对ABO基因的外显子6和7进行进一步分析。
先证者的红细胞表现为弱B表型。其血清样本中含有弱反应性抗A抗体,根据血清学特征被定义为A(w)B血型。通过血型基因分型检测到A和B等位基因。基因克隆和测序在ABO基因外显子7中鉴定出一个特征性的c.940A>G变异(ABOAW.37),该变异导致314位赖氨酸被谷氨酸取代。先证者的女儿继承了ABOAW.37等位基因。
ABO基因外显子7中的c.940A>G变异可能是导致GTA转移酶活性降低并产生Aw37表型的原因。